newsfilter
← Latest News
PR Newswire·

European Patent Office Grants Cellect Biotechnology Pivotal Patent for Stem Cells Activation

Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced ...